This inventor holds 1 USPTO granted patent. Top assignee: Aummune Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Ohad Glaich: Innovator in T-Lymphocyte Binding Aptamers
Introduction
Ohad Glaich is a notable inventor based in Givatayim, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target T-lymphocytes. His work has the potential to impact various therapeutic applications.
Latest Patents
Ohad Glaich holds a patent for T-lymphocyte binding aptamers. This patent provides innovative methods for targeting T-lymphocytes, which are crucial components of the immune system. The patent is a testament to his expertise and dedication to advancing medical science.
Career Highlights
Glaich is associated with Aummune Ltd., a company focused on developing novel therapeutic solutions. His role at Aummune Ltd. allows him to work on cutting-edge research that aims to improve patient outcomes through innovative treatments.
Collaborations
Ohad collaborates with talented individuals such as Irit Carmi-Levy and Zohar Pode. These partnerships enhance the research and development efforts at Aummune Ltd., fostering an environment of innovation and creativity.
Conclusion
Ohad Glaich is a prominent figure in the field of biotechnology, with a focus on T-lymphocyte binding aptamers. His contributions through patents and collaborations highlight his commitment to advancing medical research and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile